Amgen rival can import drug.Thousand Oaks-based biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. giant Amgen was dealt a blow last week in its bid to squash squash: see gourd; pumpkin. squash Any of various fruits of the genus Cucurbita in the gourd family, widely cultivated as vegetables and for livestock feed. The principal species are C. maxima and certain varieties of C. pepo. competitors for its anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin drugs, Epogen E·po·gen A trademark for the drug epoetin alfa. epoetin alfa Epogen, Eprex (CA) (UK), Procrit Pharmacologic class: Recombinant human erythropoietin Therapeutic class: and Aranesp. A judge at the U.S. International Trade Commission ruled that the Swiss drug maker Roche Holdings could continue to import an experimental drug called peg-EPO, or Cera, for clinical trials. Amgen contends Cera is similar to Epogen and Aranesp, the company's two top-selling drugs, and violates six U.S. patents. It filed a complaint with the trade commission to look at whether Roche, one of the largest drug makers in the world, could import Cera, which has not been approved by the Food and Drug Administration. Staff Reporter Chris Coates can be reached at (818) 316-3124 or at ccoates@sfvbj.com. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion